Dr. dan barouch
director, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center
Marshall Scholar, Class of 1993 (University of Oxford)
"We found that the immune responses are long lasting. Antibody and T-cell responses induced by the J&J vaccine last for at least eight months, with minimal to no evidence of decline over this time period. So this is very promising for a durable vaccine.”
-dr. barouch
Dan Barouch is Director of the Center for Virology and Vaccine Research at the Beth Israel Deaconess Medical Center and a William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School. Barouch’s laboratory developed a single-shot coronavirus vaccine in partnership with Johnson & Johnson. His lab and partners have also developed a HIV vaccine candidate that is currently being tested in humans, that induces a robust immune response, and it has advanced into a large-scale Phase 2B human efficacy trial in Africa and a large-scale Phase 3 licensure efficacy trial in the Americas and Europe in partnership with the U.S. National Institutes of Health, the HIV Vaccine Trials Network, the Bill & Melinda Gates Foundation, Janssen, and other entities.